vTv Therapeutics Inc (VTVT) — Cash Flow-to-Debt Ratio
vTv Therapeutics Inc (VTVT) has a Cash Flow-to-Debt Ratio of 1.03x as of March 2026, meaning its operating cash flow of $9.15 Million could theoretically repay 1% of its total liabilities ($8.85 Million) in one year. See vTv Therapeutics Inc (VTVT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
vTv Therapeutics Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for vTv Therapeutics Inc across 13 annual periods. Also explore VTVT shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for vTv Therapeutics Inc (2013–2025)
Year-by-year debt coverage analysis for vTv Therapeutics Inc. For market capitalisation and broader financial context, see VTVT stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.99x | $-25.25 Million | $25.46 Million | ▲ +6.1% |
| 2024 | -1.06x | $-25.31 Million | $23.96 Million | ▼ -63.6% |
| 2023 | -0.65x | $-19.08 Million | $29.57 Million | ▼ -16.0% |
| 2022 | -0.56x | $-15.25 Million | $27.40 Million | ▲ +70.5% |
| 2021 | -1.88x | $-19.31 Million | $10.25 Million | ▼ -15.1% |
| 2020 | -1.64x | $-18.00 Million | $11.00 Million | ▼ -28.8% |
| 2019 | -1.27x | $-23.02 Million | $18.11 Million | ▼ -332.7% |
| 2018 | -0.29x | $-26.86 Million | $91.41 Million | ▼ -18.0% |
| 2017 | -0.25x | $-44.56 Million | $178.96 Million | ▲ +24.9% |
| 2016 | -0.33x | $-48.21 Million | $145.44 Million | ▼ -52.1% |
| 2015 | -0.22x | $-36.95 Million | $169.50 Million | ▼ -262.4% |
| 2014 | -0.06x | $-30.78 Million | $511.76 Million | ▲ +53.9% |
| 2013 | -0.13x | $-41.68 Million | $319.24 Million | — |